Progelatinase B/matrix metalloproteinase-9 proenzyme as a marker of pleural inflammationKOTYZA, Jaromir; PESEK, Milos; PUZMAN, Petr et al.Experimental lung research. 2004, Vol 30, Num 4, pp 297-309, issn 0190-2148, 13 p.Article

Levels of cathepsins S and H in pleural fluids of inflammatory and neoplastic originBUNATOVA, Karin; OBERMAJER, Natasa; KOTYZA, Jaromír et al.The International journal of biological markers. 2009, Vol 24, Num 1, pp 47-51, issn 0393-6155, 5 p.Article

Denaturing capillary electrophoresis for automated detection of L858R mutation in exon 21 of the epidermal growth factor receptor gene in prediction of the outcome of lung cancer therapyBENESOVA, Lucie; PESEK, Milos; BELSANOVA, Barbora et al.Journal of separation science (Print). 2010, Vol 33, Num 15, pp 2349-2355, issn 1615-9306, 7 p.Article

Dominance of EGFR and Insignificant KRAS Mutations in Prediction of Tyrosine-kinase Therapy for NSCLC Patients Stratified by Tumor Subtype and Smoking StatusPESEK, Milos; BENESOVA, Lucie; BELSANOVA, Barbora et al.Anticancer research. 2009, Vol 29, Num 7, pp 2767-2773, issn 0250-7005, 7 p.Article

Multiplicity of EGFR and KRAS Mutations in Non-small Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase InhibitorsBENESOVA, Lucie; MINARIK, Marek; JANCARIKOVA, Dana et al.Anticancer research. 2010, Vol 30, Num 5, pp 1667-1671, issn 0250-7005, 5 p.Conference Paper

Clinical Significance of Hypermethylation Status in NSCLC: Evaluation of a 30-Gene Panel in Patients with Advanced DiseasePESEK, Milos; KOPECKOVA, Marta; BENESOVA, Lucie et al.Anticancer research. 2011, Vol 31, Num 12, pp 4647-4652, issn 0250-7005, 6 p.Article

Prognostic Significance of TIMP-1 in Non-small Cell Lung CancerPESTA, Martin; KULDA, Vlastimil; VYCITAL, Ondrej et al.Anticancer research. 2011, Vol 31, Num 11, pp 4031-4038, issn 0250-7005, 8 p.Article

Gefitinib Versus Vinorelbine in Chemotherapy-Naive Elderly Patients With Advanced Non-Small-Cell Lung Cancer (INVITE) : A Randomized, Phase II StudyCRINO, Lucio; CAPPUZZO, Federico; DUFFIELD, Emma L et al.Journal of clinical oncology. 2008, Vol 26, Num 26, pp 4253-4260, issn 0732-183X, 8 p.Article

Prognostic Significance of ERCC1, RRM1 and BRCA1 in Surgically-treated Patients with Non-small Cell Lung CancerPESTA, Martin; KULDA, Vlastimil; FIALA, Ondrej et al.Anticancer research. 2012, Vol 32, Num 11, pp 5003-5010, issn 0250-7005, 8 p.Article

Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer : The tarceva lung cancer investigation trialPLUZANSKA, Anna; SZCZESNA, Aleksandra; JANASKOVA, Terezie et al.Journal of clinical oncology. 2007, Vol 25, Num 12, pp 1545-1552, issn 0732-183X, 8 p.Article

Vitamin D in Colorectal, Breast, Prostate and Lung Cancer: A Pilot StudyPAZDIORA, Petr; SVOBODOVA, Sarka; TRESKA, Vladislav et al.Anticancer research. 2011, Vol 31, Num 10, pp 3619-3621, issn 0250-7005, 3 p.Article

Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non-small-cell lung cancerHEYMACH, John V; JOHNSON, Bruce E; KENNEDY, Sarah J et al.Journal of clinical oncology. 2007, Vol 25, Num 27, pp 4270-4277, issn 0732-183X, 8 p.Article

Therapy of small cell lung cancer with emphasis on oral topotecanPIRKER, Robert; BERZINEC, Peter; STANCULEANU, Dana et al.Lung cancer. 2010, Vol 70, Num 1, pp 7-13, issn 0169-5002, 7 p.Article

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trialZATLOUKAL, Petr; PETRUZELKA, Lubos; HORENKOVA, Eva et al.Lung cancer. 2003, Vol 41, Num 3, pp 321-331, issn 0169-5002, 11 p.Article